Valbiotis Current Deferred Revenue from 2010 to 2026
| ALVAL Stock | EUR 1.10 0.02 1.79% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 4 M | Current Value 2 M | Quarterly Volatility 1.9 M |
Check Valbiotis SAS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Valbiotis SAS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 593.5 K, Interest Expense of 227.4 K or Selling General Administrative of 4.5 M, as well as many indicators such as Price To Sales Ratio of 150, Dividend Yield of 0.0 or PTB Ratio of 2.53. Valbiotis financial statements analysis is a perfect complement when working with Valbiotis SAS Valuation or Volatility modules.
Valbiotis | Current Deferred Revenue |
Evaluating Valbiotis SAS's Current Deferred Revenue across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Valbiotis SAS's fundamental strength.
Latest Valbiotis SAS's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Valbiotis SAS over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Valbiotis SAS's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Valbiotis SAS's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Valbiotis Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 1,575,204 | |
| Geometric Mean | 473,218 | |
| Coefficient Of Variation | 118.24 | |
| Mean Deviation | 1,715,299 | |
| Median | 132,000 | |
| Standard Deviation | 1,862,458 | |
| Sample Variance | 3.5T | |
| Range | 4.5M | |
| R-Value | 0.77 | |
| Mean Square Error | 1.5T | |
| R-Squared | 0.60 | |
| Significance | 0.0003 | |
| Slope | 285,139 | |
| Total Sum of Squares | 55.5T |
Valbiotis Current Deferred Revenue History
About Valbiotis SAS Financial Statements
Valbiotis SAS shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Valbiotis SAS investors may analyze each financial statement separately, they are all interrelated. The changes in Valbiotis SAS's assets and liabilities, for example, are also reflected in the revenues and expenses on on Valbiotis SAS's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 4 M | 2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Valbiotis Stock Analysis
When running Valbiotis SAS's price analysis, check to measure Valbiotis SAS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valbiotis SAS is operating at the current time. Most of Valbiotis SAS's value examination focuses on studying past and present price action to predict the probability of Valbiotis SAS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valbiotis SAS's price. Additionally, you may evaluate how the addition of Valbiotis SAS to your portfolios can decrease your overall portfolio volatility.